Fibrinogen as a factor of thrombosis: Experimental study

Thrombosis Research

Volumn 90, Issue 2, 1998, Pages 57-64

  Zoutremepuich, F ^a   Aguejouf, O ^a   Belougne Malfatti, E ^a   Doutremepuich, C ^a  

^a Faculté de Pharmacie   (France)

Author keywords

'Acute phase'; Fibrinogen; Lesion; Post operative period; Thrombus formation

Indexed keywords

ADENOSINE DIPHOSPHATE; COLLAGEN; FIBRINOGEN; FIBRINOGEN RECEPTOR; THROMBIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; FIBRINOGEN BLOOD LEVEL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RISK FACTOR; THROMBOEMBOLISM; THROMBOGENESIS; THROMBOSIS;

EID: 0032522242     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(98)00025-5     Document Type: Article

References (23)

1. Ridker P.M. Association of hemostatic and thrombotic factors with cardiovascular risk. Schafer A. Molecular Mechanism of Hypercoagulable States. 1997;RG Landes, New York.
2. Ridker P.M. Fibrinolytic and inflammatory markers for arterial occlusion. The evolving epidemiology of thrombosis and hemostasis Thromb Haemost. 78(1):1997;53-59.
3. Siess W. Molecular mechanisms of platelet activation. Physiol Rev. 69:1989;58-178.
4. Doolittle R.F., Watt K.W.K., Cottrell B.A., Strong D.D., Riley M. The amino acid sequence of the a-chain of human fibrinogen. Nature. 280:1972;464-468.
5. Chesebro J.H., Badimon L., Fuster V. New approaches to treatment of myocardial infarction. Am J Cardiol. 65:1990;12C-19C.
6. Doutremepuich F., Aguejouf O., Azougagh Oualane F., Doutremepuich C. Prevention of laser arterial thrombus formation with unfractionated heparin. Haemostasis. 23:1993;244-248.
7. Doutremepuich F., Aguejouf O., Imbault P., Azougagh Oualane F., Doutremepuich C. Effect of low molecular weight heparin/non steroidal anti-inflammatory drugs association on an experimental thrombosis induced by laser. Thromb Res. 77(4):1995;311-319.
8. Vesvres M.H., Doutremepuich F., Lalanne M.C., Doutremepuich C. Effect of aspirin on embolization in an arterial model of laser-induced thrombus formation. Haemostasis. 23:1993;8-12.
9. Cardinal D., Flower R. The electronic aggregometer. A novel device for assessing platelet behavior in blood J Pharmacol Methods. 3:1980;135-138.
10. Ruggeri Z.M. The role of von Willebrand factor and fibrinogen in the initiation of platelet adhesion to thrombogenic surface. Thromb Haemost. 74(1):1995;460-463.
11. Hantgan R.R., Hindriks G., Taylor R.G., Sixma J.J., De Groot P.G. Glycoprotein Ib, von Willebrand Factor, and glycoprotein IIb:IIIa are all involved in platelet adhesion to fibrin in flowing whole blood. Blood. 76:1990;345-353.
12. Flow E.F., Ginsbery M.H. Cellular adhesion. GP IIb/IIIa as prototypic adhesion receptor Coller B.S. Progress in Hemostasis and Thrombosis. Vol. 9. 1989;117-156 W.B. Saûder Company, New York.
13. Humphries SE, Cook M, Dubowitz M, Stir- ling Y, Meade TW. Role of genetic variation at the fibrinogen locus in determination of plas- ma fibrinogen concentrations. Lancet 1987;i: 1452-4.
14. Koster T., Rosendaal F.R., Reitsma P.H., van der Velden P.A., Briet E., Vandenbroucke J.P. Factor VII and fibrinogen level as risk factors for venous thrombosis. A case-control study of plasma levels and DNA polymorphisms. The Leiden Thrombophilia Study (LETS). Thromb Haemost. 71(6):1994;719-722.
15. Mead TW, Mellows S, Brozovic M, Miller GJ, Chakrabarti RR, North WRS, Haines AP, Stirling Y, Imeson JD, Thompson SG. Haemostatic function and ischaemic heart disease: Principal results of the Northwick Park Heart Study. Lancet 1986;i:533-7.
16. Heinrich J., Schulte H., Schonfeld R., Kohler E., Assmann G. Association of variables of coagulation fibrinolysis and acute-phase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brain. Thromb Haemost. 73(3):1995;374-379.
17. Ygge J. Change in blood coagulation and fibrinolysis during the post-operative period. Amer J Surg. 119:1970;225-232.
18. Hirsh J. Blood tests for the diagnosis of venous and arterial thrombosis. Blood. 57:1981;1-8.
19. Hirsh J. Hypercoagulability. Semin Haematol. 14:1977;409-425.
20. Kushner I. The phenomenon of the acute phase response. Ann NY Acad Sci. 389:1982;39-48.
21. Dinarello C.A., Mier J.W. Interleukin. Ann Rev Med. 37:1986;173-178.
22. Kampschidt R.F., Upchurch H.F., Pulliam L.A. Characterization of leukocyte-derived endogenous mediator responsible for increased plasma fibrinogen. Ann NY Acad Sci. 389:1982;338-351.
23. Chooi C.C., Gallen A.S. Acute phase reaction, fibrinogen level and thrombus size. Thromb Res. 53:1989;493-501.